NCT06235892View on ClinicalTrials.gov

Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure

PHASE3RecruitingINTERVENTIONAL
Enrollment

332

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

August 10, 2026

Study Completion Date

October 10, 2026

Conditions
Organ Grafts
Interventions
DRUG

TACROLIMUS

TACROLIMUS 2-3.5 ng/ml

Trial Locations (3)

44000

RECRUITING

CHU de NANTES, Nantes

Unknown

NOT_YET_RECRUITING

Oslo University Hospital, Oslo

NOT_YET_RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

All Listed Sponsors
lead

Nantes University Hospital

OTHER